Changeflow GovPing European Union

Recent changes

Favicon for changeflow.com

EPO Patent Publication: Fecal Microbiome Spatial Characterization

The European Patent Office has published patent application EP2026030670A1 concerning the spatial characterization of the fecal microbiome. The publication date is March 18, 2026, and it includes various International Patent Classifications related to biotechnology and medical applications.

Routine Notice Healthcare
Favicon for changeflow.com

EPO Patent Publication: Adhesion Molecules for Targeted Infiltration of Therapeutic Cells

The European Patent Office has published patent application EP2026030704A1 concerning adhesion molecules for targeted infiltration of therapeutic cells. The publication date is March 18, 2026, and it relates to advancements in biotechnology and pharmaceutical applications.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent Publication: Rock Hyrax IPSC Generation Methods

The European Patent Office has published a patent application (EP2026030659A1) detailing methods for generating induced pluripotent stem cells (IPSC) from rock hyrax. The publication date is March 18, 2026, and it includes IPC classifications related to cell culture and genetic manipulation.

Routine Notice Healthcare
Favicon for changeflow.com

EPO Patent EP3394277B1: Improved Granular Starch Conversion Enzymes

The European Patent Office has granted patent EP3394277B1 for improved granular starch conversion enzymes and methods. This patent, effective March 18, 2026, covers specific biotechnological innovations in enzyme technology.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent Granted for Mobile Cell Separation Device and Method

The European Patent Office has granted patent EP3587561B1 for a device and method for separating mobile cells. The patent, listing Herberto Ernesto Héctor Repetto as the inventor, was published on March 18, 2026, and covers various IPC classifications related to cell separation and medical devices.

Routine Notice Healthcare
Favicon for changeflow.com

EPO Patent EP3262065B1: Dystroglycanopathy Treatment Methods

The European Patent Office has granted patent EP3262065B1 for methods and compositions for treating dystroglycanopathy disorders. This patent, effective March 18, 2026, covers specific treatment approaches and related compositions.

Routine Rule Pharmaceuticals
Favicon for changeflow.com

EPO Patent: Wheat Stripe Rust Resistance Genes

The European Patent Office (EPO) has published a limitation for patent EP3370509C0 concerning wheat stripe rust resistance genes and methods of use. The patent, listing Matthew James Moscou and Andrew Marc Dawson as inventors, is set to be limited on March 18, 2026.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent Grant EP2699693B1 for Isolating Target Analyte

The European Patent Office has granted patent EP2699693B1 for methods of isolating a target analyte from a heterogeneous sample. The patent lists multiple inventors and covers various International Patent Classifications related to molecular biology and analytical chemistry.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent Granted: Lung Cancer Detection Method and Kit

The European Patent Office has granted patent EP3467503B1 for a lung cancer detection method and kit. The patent was granted on March 18, 2026, with Daisuke Nakata listed as the inventor. This grant pertains to intellectual property within the biotechnology and healthcare sectors.

Routine Notice Healthcare
Favicon for changeflow.com

EPO Grants Patent for Antigen-Presenting Cell-Mimetic Scaffolds

The European Patent Office (EPO) has granted patent EP3484448B1 for antigen-presenting cell-mimetic scaffolds and methods for their creation and use. The patent was published on March 18, 2026, and lists Alexander Sing Cheung and David J. Mooney as inventors.

Routine Notice Pharmaceuticals

Showing 311–320 of 1,115 changes

1 30 31 32 33 34 112

Get European Union alerts

Daily digest of regulatory changes. AI-summarized, no noise.

Free. Unsubscribe anytime.